TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J&J wins U.S. approval for TB tablet

JNJ $70.10 +$0.62

at close on MONDAY

By Anna Edney C.2012 Bloomberg News
Monday, Dec. 31, 2012, 10:30 p.m.
 

Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.

The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.

While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Gas drilling company withdraws application for forced pooling in Western Pennsylvania
  2. Healthy PA expands number of recipients but cuts benefits
  3. Dairy Queen victim of malware attack
  4. Hershey unwraps new corporate logo
  5. Google tests Project Wing drone delivery
  6. Trib 30 stock index gains 4.85% in August
  7. Consumer spending dips 0.1% in July as auto sales pull back
  8. Cadillac faces SUV challenge
  9. Government approves compromise on Corbett’s alternative Medicaid plan
  10. Fiat-Chrysler shares may hit market soon
  11. Consumer sentiment improves slightly in August
Subscribe today! Click here for our subscription offers.